Mnkd corporation
Web12 apr. 2024 · MannKind Corporation (NASDAQ:MNKD)’s beta value is currently sitting at 1.58, while the Average True Range indicator is currently displaying 0.18. With analysts defining $5.00-$8.00 as the low and high price targets, we arrive at a consensus price target of $6.67 for the trailing 12-month period. Web10 apr. 2024 · MannKind Corporation (MNKD) has experienced a 4.01% rise in stock performance for the past week, with a -13.18% drop in the past month, and a -15.99% drop in the past quarter. The volatility ratio for the week is 3.27%, and the volatility levels for the past 30 days are at 4.10% for MNKD.
Mnkd corporation
Did you know?
Web17 mrt. 2024 · MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company’s lead product is Afrezza Inhalation Powder, which is an inhaled insulin … WebMannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The ...
WebDANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development … Find the latest MannKind Corporation (MNKD) stock discussion in Yahoo … Discover historical prices for MNKD stock on Yahoo Finance. View daily, weekly or … See MannKind Corporation (MNKD) stock analyst estimates, including earnings … See the company profile for MannKind Corporation (MNKD) including business … View the basic MNKD option chain and compare options of MannKind … DANBURY, Conn., March 27, 2024 (GLOBE NEWSWIRE) -- MannKind … Find out the direct holders, institutional holders and mutual fund holders for … Find out all the key statistics for MannKind Corporation (MNKD), including valuation … Web12 apr. 2024 · MannKind Corporation (NASDAQ:MNKD)’s beta value is currently sitting at 1.58, while the Average True Range indicator is currently displaying 0.18. With analysts …
Web2 mrt. 2024 · And this is just one of our 5 Best Growth Stocks To Own For 2024. Sponsored. The average price suggested by analysts for MNKD is $6.67, which is $1.05 above the current market price. The public float for MNKD is 246.92M, and currently, shorts hold a 14.00% of that float. The average trading volume for MNKD on March 02, 2024 was … WebMNKD Growth Metrics. Its 2 year net income to common stockholders growth rate is now at -102.86%. Its 3 year cash and equivalents growth rate is now at 91.81%. Its year over year price growth rate is now at -23.63%. Over the past 33 months, MNKD's revenue has gone up $13,188,000.
Web25 mrt. 2024 · Data on historical trading for MannKind Corporation (NASDAQ:MNKD) indicates that the trading volumes over the past 10 days have averaged 3.53 million and over the past 3 months, they’ve averaged 3.36 million. According to company’s latest data on outstanding shares, there are 263.45 million shares outstanding.
Web13 apr. 2024 · MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and … menuiserie lougarre labarthe inardWebGet MannKind Corp (MNKD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. how much you can contribute to hsaWeb10 feb. 2024 · MannKind Corporation (MNKD) CEO Michael Castagna on Q3 2024 Results - Earnings Call Transcript. Seeking Alpha • 11/10/21. Recap: MannKind Q3 Earnings. Benzinga • 11/09/21. Mannkind Corporation Closes Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds. menuiserie mateco hames-boucresWeb10 aug. 2024 · DANBURY, Conn., March 27, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices... how much you can borrow for mortgageWebWhat’s new at MannKind? From announcements to financial results, learn the latest about MannKind Corporation by reading our press releases and about our events. menuiserie pvc oknoplast gamme 70 charme miniWebMannKind Corp. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic products and devices for those with endocrine and … menuiserie bois thononWebAt MannKind, we are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. Our … how much you can contribute to 401k